Crestline Management
Latest statistics and disclosures from Crestline Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are DNLI, SANA, EGHT, and represent 100.00% of Crestline Management's stock portfolio.
- Reduced shares in these 2 stocks: DNLI (-$9.9M), SANA.
- Crestline Management was a net seller of stock by $-12M.
- Crestline Management has $53M in assets under management (AUM), dropping by -8.20%.
- Central Index Key (CIK): 0001536054
Tip: Access up to 7 years of quarterly data
Positions held by Crestline Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Crestline Management
Crestline Management holds 3 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Denali Therapeutics (DNLI) | 87.0 | $46M | -17% | 2.8M | 16.51 |
|
| Sana Biotechnology (SANA) | 9.3 | $5.0M | -32% | 1.2M | 4.07 |
|
| 8x8 (EGHT) | 3.7 | $2.0M | 991k | 1.97 |
|
Past Filings by Crestline Management
SEC 13F filings are viewable for Crestline Management going back to 2011
- Crestline Management 2025 Q4 filed Feb. 17, 2026
- Crestline Management 2025 Q3 filed Nov. 14, 2025
- Crestline Management 2025 Q2 filed Aug. 14, 2025
- Crestline Management 2025 Q1 filed May 15, 2025
- Crestline Management 2024 Q4 filed Feb. 14, 2025
- Crestline Management 2024 Q3 filed Nov. 13, 2024
- Crestline Management 2024 Q1 filed May 14, 2024
- Crestline Management 2023 Q4 filed Feb. 12, 2024
- Crestline Management 2023 Q3 filed Nov. 14, 2023
- Crestline Management 2023 Q2 filed Aug. 14, 2023
- Crestline Management 2023 Q1 filed May 15, 2023
- Crestline Management 2022 Q4 filed Feb. 13, 2023
- Crestline Management 2022 Q3 filed Nov. 14, 2022
- Crestline Management 2022 Q2 filed Aug. 12, 2022
- Crestline Management 2022 Q1 filed May 16, 2022
- Crestline Management 2021 Q4 filed Feb. 14, 2022